Nantkwest / Immunitybio -> IBRX WKN: A2QQ2E ISIN: US45256X1037 Kürzel: IBRX Forum: Aktien User: captainpump97

Wo seht ihr neben einer noch möglichen KE die Risiken kurstechnisch? Die baldige Zulassung in der EU und weitere vielversprechenden Studienergebnisse müssten doch bis Ende des Jahren noch den ein oder anderen Short die Seite wechseln lassen, nicht?

https://x.com/drpatsoonshiong/status/1962625970286010480?s=46 Da wurde gestern wieder fleißig in die Tasten gehauen.. 🤔

Zumindest handelt es sich scheinbar mal um eine aussagekräftige Stichprobe…

Kann das jemand Einschätzen noch?

Das klingt aehr nach einem Durchbruch! Next week we will share our data in 86 patients with lung cancer who failed chemo and some who failed both chemo and radiation and all 86 who progressed on checkpoints. Our study involved accepting these 2nd and 3rd line patients and WHILE THEY WERE STILL PROGRESSING on the checkpoint, to add the Bioshield and then measure for overall survival with the same checkpoint plus Bioshield. The test was: did lymphocytes ( NK cells and T cells) matter and could these patients be rescued after 2nd and 3rd line therapy even after destruction of their immune system by current standards of care. Data coming: NK cells matter!! But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?

Das klingt aehr nach einem Durchbruch! Next week we will share our data in 86 patients with lung cancer who failed chemo and some who failed both chemo and radiation and all 86 who progressed on checkpoints. Our study involved accepting these 2nd and 3rd line patients and WHILE THEY WERE STILL PROGRESSING on the checkpoint, to add the Bioshield and then measure for overall survival with the same checkpoint plus Bioshield. The test was: did lymphocytes ( NK cells and T cells) matter and could these patients be rescued after 2nd and 3rd line therapy even after destruction of their immune system by current standards of care. Data coming: NK cells matter!! But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?

Naja am Ende läuft der Verkauf so richtig ja erst seit 1.1. ( J Code) Jetzt müssen ma mal den November abwarten, dann sehen wir weiter wie es mit dem Umsatz aussieht.